Covaxin Bharat Biotech
-
{
- All
- News
- Videos
-
Top Medical Body Slams Study On Covaxin Safety, Side-Effects, Wants Apology
The Indian Council of Medical Research, or ICMR, has distanced itself from a follow-up study by two Banaras Hindu University professors that said nearly a third of 926 individuals who got the India-made Covaxin shot reported serious side-effects.
-
No Side Effects From Our Vaccine: Covaxin Maker Amid AstraZeneca Row
The Covaxin was developed with a single-minded focus on safety first, said its maker Bharat Biotech on Thursday, days after British pharma giant AstraZeneca admitted that its Covid vaccine can cause rare side effects.
-
No External Pressure To Accelerate Development Of Covaxin: Bharat Biotech
Covid-19 vaccine Covaxin maker Bharat Biotech today said there was no external pressure on the firm to speed up its development.
-
50 Million Doses Of Covaxin Set To Expire Early 2023: Report
Nearly 50 million doses of Bharat Biotech's COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no takers owing to poor demand, company sources said.
-
"Covaxin Safe For Kids Aged 2-18": Here's What Bharat Biotech Says On Side-Effects
Data on Covaxin for children has been published online in The Lancet Infectious Diseases journal on June 16
-
Covaxin Cleared For 6-12 Age Group, Corbevax For 5-12-Year-Olds
The Drugs Controller General of India (DCGI) today gave emergency use authorisation to Bharat Biotech's Covaxin for children between the age group of 6-12 amid an uptick in the Covid cases in schools.
-
Covaxin Production Slowed Down, This Is What Bharat Biotech Will Focus On
Bharat Biotech on Friday said it is temporarily slowing down production of its COVID-19 vaccine Covaxin across its manufacturing units.
-
WHO In Talks With Covaxin Maker Bharat Biotech To Join Its Tech Access Pool: Official
The World Health Organisation is in negotiations with Bharat Biotech, whose COVID-19 vaccine Covaxin was given Emergency Use Listing, to join the global health agency's technology access pool to share technology and know how, a top WHO official said
-
Australia Recognises Covaxin For Travel As It Eases Border Curbs
Earlier, the Therapeutic Goods Administration (TGA) had recommended that only the vaccines approved for use in Australia, and Covishield from India and Sinovac from China be recognised for the purposes of travel and other restrictions.
-
"Really Trust Indian Industry": WHO, Asked About Delay In Covaxin Nod
India's Bharat Biotech has been submitting data on the EUL of Covaxin "regularly and very quickly" to a technical committee which hopes to have a final recommendation to the WHO next week, a top official of the global health agency said on Thursday
-
Clarifications From Bharat Biotech On Covaxin Likely By Weekend: WHO
The World Health Organisation on Wednesday said it expects to receive clarifications from Bharat Biotech by the end of this week on its COVID-19 vaccine -- Covaxin.
-
Bharat Biotech Ends Brazil Agreement With 2 Firms Amid Political Row
Drugmaker Bharat Biotech on Friday said it has scrapped agreements with two Brazilian companies amid controversy over a $324 million deal between the South American country and Bharat Biotech for the import of 20 million doses of Covaxin.
-
Bharat Biotech Dossier Under Review For Covaxin Emergency Use Listing: WHO
Officials of the World Health Organisation (WHO) had a meeting with the Bharat Biotech and its dossier for Emergency Use Listing of Covaxin is under review by technical experts, Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia said.
-
Bharat Biotech, WHO To Meet Over Covaxin Emergency Use Listing On June 23
In a major boost for Bharat Biotech, the World Health Organisation (WHO) has accepted its Expression of Interest (EoI) for COVID-19 vaccine Covaxin and scheduled a pre-submission meeting on June 23.
-
Made Preparations For Vaccination After Bharat Biotech Assurance: Delhi Government To High Court
The Delhi government told the Delhi High Court on Friday that it made preparations for vaccinating people with Covaxin based on its manufacturer Bharat Biotech's assurance.
-
Top Medical Body Slams Study On Covaxin Safety, Side-Effects, Wants Apology
The Indian Council of Medical Research, or ICMR, has distanced itself from a follow-up study by two Banaras Hindu University professors that said nearly a third of 926 individuals who got the India-made Covaxin shot reported serious side-effects.
-
No Side Effects From Our Vaccine: Covaxin Maker Amid AstraZeneca Row
The Covaxin was developed with a single-minded focus on safety first, said its maker Bharat Biotech on Thursday, days after British pharma giant AstraZeneca admitted that its Covid vaccine can cause rare side effects.
-
No External Pressure To Accelerate Development Of Covaxin: Bharat Biotech
Covid-19 vaccine Covaxin maker Bharat Biotech today said there was no external pressure on the firm to speed up its development.
-
50 Million Doses Of Covaxin Set To Expire Early 2023: Report
Nearly 50 million doses of Bharat Biotech's COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no takers owing to poor demand, company sources said.
-
"Covaxin Safe For Kids Aged 2-18": Here's What Bharat Biotech Says On Side-Effects
Data on Covaxin for children has been published online in The Lancet Infectious Diseases journal on June 16
-
Covaxin Cleared For 6-12 Age Group, Corbevax For 5-12-Year-Olds
The Drugs Controller General of India (DCGI) today gave emergency use authorisation to Bharat Biotech's Covaxin for children between the age group of 6-12 amid an uptick in the Covid cases in schools.
-
Covaxin Production Slowed Down, This Is What Bharat Biotech Will Focus On
Bharat Biotech on Friday said it is temporarily slowing down production of its COVID-19 vaccine Covaxin across its manufacturing units.
-
WHO In Talks With Covaxin Maker Bharat Biotech To Join Its Tech Access Pool: Official
The World Health Organisation is in negotiations with Bharat Biotech, whose COVID-19 vaccine Covaxin was given Emergency Use Listing, to join the global health agency's technology access pool to share technology and know how, a top WHO official said
-
Australia Recognises Covaxin For Travel As It Eases Border Curbs
Earlier, the Therapeutic Goods Administration (TGA) had recommended that only the vaccines approved for use in Australia, and Covishield from India and Sinovac from China be recognised for the purposes of travel and other restrictions.
-
"Really Trust Indian Industry": WHO, Asked About Delay In Covaxin Nod
India's Bharat Biotech has been submitting data on the EUL of Covaxin "regularly and very quickly" to a technical committee which hopes to have a final recommendation to the WHO next week, a top official of the global health agency said on Thursday
-
Clarifications From Bharat Biotech On Covaxin Likely By Weekend: WHO
The World Health Organisation on Wednesday said it expects to receive clarifications from Bharat Biotech by the end of this week on its COVID-19 vaccine -- Covaxin.
-
Bharat Biotech Ends Brazil Agreement With 2 Firms Amid Political Row
Drugmaker Bharat Biotech on Friday said it has scrapped agreements with two Brazilian companies amid controversy over a $324 million deal between the South American country and Bharat Biotech for the import of 20 million doses of Covaxin.
-
Bharat Biotech Dossier Under Review For Covaxin Emergency Use Listing: WHO
Officials of the World Health Organisation (WHO) had a meeting with the Bharat Biotech and its dossier for Emergency Use Listing of Covaxin is under review by technical experts, Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia said.
-
Bharat Biotech, WHO To Meet Over Covaxin Emergency Use Listing On June 23
In a major boost for Bharat Biotech, the World Health Organisation (WHO) has accepted its Expression of Interest (EoI) for COVID-19 vaccine Covaxin and scheduled a pre-submission meeting on June 23.
-
Made Preparations For Vaccination After Bharat Biotech Assurance: Delhi Government To High Court
The Delhi government told the Delhi High Court on Friday that it made preparations for vaccinating people with Covaxin based on its manufacturer Bharat Biotech's assurance.
